Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Edward B Skibo. (1998) Pyrrolobenzimidazoles in cancer treatment. Expert Opinion on Therapeutic Patents 8:6, pages 673-701.
Read now
Read now
Eric J. Small, Linda J. Fippin & Sarah P. Whisenant. (1998) Pyrazoloacridine for the Treatment of Hormone-Refractory Prostate Cancer. Cancer Investigation 16:7, pages 456-461.
Read now
Read now
Ozcan Balat & Claire Verschraegen. (1995) Section Review: Oncologic, Endocrine & Metabolic: Topoisomerase I inhibitors in gynaecologic cancers. Expert Opinion on Investigational Drugs 4:12, pages 1217-1232.
Read now
Read now
Thomas Corbett, Fred Valeriote, Patricia Lorusso, Lisa Polin, Chiab Panchapor, Susan Pugh, Kathryn White, Juiwanna Knight, Lisa Demchik, Julie Jones, Lynne Jones, Nancy Lowichik, Laura Biernat, Brenda Foster, Antoinette Wozniak, Loretta Lisow, Manuel Valdivieso, Larry Baker, Wilbur Leopold, Judith Sebolt, Marie-Christine Bissery, Ken Mattes, Janet Dzubow, James Rake, Robert Perni, Mark Wentland, Susan Coughlin, J. Michael Shaw, Gary Liversidge, Elaine Liversidge, Joseph Bruno, Pramod Sarpotdar, Richard Moore & Gregory Patterson. (1995) Tumor Models and the Discovery and Secondary Evaluation of Solid Tumor Active Agents. International Journal of Pharmacognosy 33:sup1, pages 102-122.
Read now
Read now
Articles from other publishers (20)
Bhuvaneswari Ramaswamy, Ewa Mrozek, John Philip Kuebler, Tanios Bekaii-Saab & Eric H. Kraut. (2009) Phase II trial of pyrazoloacridine (NSC#366140) in patients with metastatic breast cancer. Investigational New Drugs 29:2, pages 347-351.
Crossref
Crossref
Patrick McConville, William L. Elliott, Alicia Kreger, Richard Lister, Jonathan B. Moody, Erin Trachet, Frank Urban & W. R. Leopold. 2007. In Vivo Imaging of Cancer Therapy. In Vivo Imaging of Cancer Therapy
13
32
.
Ioannis K. Kostakis, Nicole Pouli, Panagiotis Marakos, Alexios-Leandros Skaltsounis, Harris Pratsinis & Dimitris Kletsas. (2006) Design and synthesis of novel amino-substituted xanthenones and benzo[b]xanthenones: Evaluation of their antiproliferative activity and their ability to overcome multidrug resistance toward MES-SA/D×5 cells. Bioorganic & Medicinal Chemistry 14:9, pages 2910-2934.
Crossref
Crossref
Evanthia Galanis, Jan C. Buckner, Matthew J. Maurer, Joel M. Reid, Mary J. Kuffel, Matthew M. Ames, Bernd W. Scheithauer, Julie E. Hammack, George Pipoly & Steven A. Kuross. (2005) Phase I/II trial of pyrazoloacridine and carboplatin in patients with recurrent glioma: A North Central Cancer Treatment Group trial. Investigational New Drugs 23:5, pages 495-503.
Crossref
Crossref
Katherine K. Matthay & Brian H. Kushner. 2005. Neuroblastoma. Neuroblastoma
193
211
.
Gabriele Cruciani, Paolo Benedetti, Gianluigi Caltabiano, Daniele F Condorelli, Cosimo G Fortuna & Giuseppe Musumarra. (2004) Structure-based rationalization of antitumor drugs mechanism of action by a MIF approach. European Journal of Medicinal Chemistry 39:3, pages 281-289.
Crossref
Crossref
YanPing Hu, Awtar Krishan, WeiJia Nie, Kasi S. Sridhar, Lawrence D. Mayer & Marcel Bally. (2004) Synergistic Cytotoxicity of Pyrazoloacridine with Doxorubicin, Etoposide, and Topotecan in Drug-Resistant Tumor Cells. Clinical Cancer Research 10:3, pages 1160-1169.
Crossref
Crossref
E. Claire Dees, Eric K. Rowinsky, Dennis A. Noe, Seamus O'Reilly, Alex A. Adjei, Kathy Elza-Brown & Ross C. Donehower. (2003) A Phase I and Pharmacologic Study of Pyrazoloacridine and Cisplatin in Patients with Advanced Cancer. Investigational New Drugs 21:1, pages 75-84.
Crossref
Crossref
Alex A. Adjei, Joel M. Reid, Charles Erlichman, Jeff A. Sloan, Henry C. Pitot, Steven R. Alberts, Richard M. Goldberg, Lorelei J. Hanson, Stacie Ruben, Scott A. Boerner, Pamela Atherton, Matthew M. Ames & Scott H. Kaufmann. (2002) A Phase I and Pharmacologic Study of Pyrazoloacridine (NSC 366140) and Carboplatin in Patients with Advanced Cancer. Investigational New Drugs 20:3, pages 297-304.
Crossref
Crossref
Jacqueline Vuky, John McCaffrey, Michelle Ginsberg, Tania Mariani, Dean F. Bajorin, George J. Bosl & Robert J. Motzer. (2000) Phase II Trial of Pyrazoloacridine in Patients with Cisplatin-Refractory Germ Cell Tumors. Investigational New Drugs 18:3, pages 265-267.
Crossref
Crossref
Alex A. Adjei. (1999) Current status of pyrazoloacridine as an anticancer agent. Investigational New Drugs 17:1, pages 43-48.
Crossref
Crossref
William J. Berg, John McCaffrey, Lawrence H. Schwartz, Tania Mariani, Madhu Mazumdar & Robert J. Motzer. (1998) A phase II study of pyrazoloacridine in patients with advanced renal cell carcinoma. Investigational New Drugs 16:4, pages 337-340.
Crossref
Crossref
Jean‐Pierre Galy, Sandrine Morel, Gérard Boyer & José Elguero. (2009) Tetracyclic derivatives of acridine. Heterofused acridines. Journal of Heterocyclic Chemistry 33:6, pages 1551-1560.
Crossref
Crossref
Jean L. Grem, Pedro M. Politi, Stacey L. Berg, Nabil M. Benchekroun, Mahendra Patel, Frank M. Balis, Birandra K. Sinha, William Dahut & Carmen J. Allegra. (1996) Cytotoxicity and DNA damage associated with pyrazoloacridine in MCF-7 breast cancer cells. Biochemical Pharmacology 51:12, pages 1649-1659.
Crossref
Crossref
S Berg. (1996) Status of new anthrapyrazole and pyrazoloacridine derivatives. Critical Reviews in Oncology/Hematology 22:2, pages 79-87.
Crossref
Crossref
Jeffrey S. Abrams, Timothy D. Moore & Michael Friedman. (1994) New chemotherapeutic agents for breast cancer. Cancer 74:S3, pages 1164-1176.
Crossref
Crossref
Ram Prasad K. Kodukulla, S. Hariharan & Girish K. Trivedi. (1994) Stereochemical investigation in the 1,3-dipolar cycloadditions of 3-nitro-2-phenyl-2H-1-benzopyrans to diazoalkanes: Synthesis and antimicrobial activity of novel benzopyranopyrazole derivatives. Tetrahedron 50:16, pages 4623-4634.
Crossref
Crossref
Daniel L. Dexter, Melody Diamond, Janet Creveling & Shih-Fong Chen. (1993) Chemotherapy of mammary carcinomas arising in ras transgenic mice. Investigational New Drugs 11:2-3, pages 161-168.
Crossref
Crossref
Linda M. Benson, Andy J. Tomlinson, Joel M. Reid, Denise L. Walker, Matthew M. Ames & Stephen Naylor. (2005)
Study of
in Vivo
pyrazoloacridine metabolism by capillary electrophoresis using isotachophoresis preconcentration in non‐aqueous separation buffer
. Journal of High Resolution Chromatography 16:5, pages 324-326.
Crossref
Crossref
Michael Grever & Louis Malspeis. (1993) The Discovery and Development of New Antileukemic Drugs. Hematology/Oncology Clinics of North America 7:1, pages 233-254.
Crossref
Crossref